Century Therapeutics Inc. Common Stock (IPSC)

About IPSC

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308,…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

78

Website

www.centurytx.com/

Fundamentals

1-day range

$1.99$2.2

Market cap

$357.10M

P/E (trailing)

—

P/E (forward)

-4.48

EPS (trailing)

$-1.11

Dividend yield

—

Beta

1.64

Avg. volume

1.17M

Forecasts

4 analyst ratings

Century Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• IPSC

  Century Therapeutics Inc. Common Stock

  $2.03

  ▼ 9.19%
  Market cap $357.10MP/E —
  $0.435$3.04
• AGEN

  Agenus Inc. Common Stock

  $7.67

  ▼ 1.79%
  Market cap $349.96MP/E 4.88
  $2.71$8.85
• PALI

  Palisade Bio Inc. Common Stock

  $2.01

  ▼ 4.74%
  Market cap $336.74MP/E 3.25
  $0.53$2.86
• FENC

  Fennec Pharmaceuticals Inc. Common Stock

  $12.19

  ▲ 3.57%
  Market cap $334.56MP/E —
  $5.65$13.25
• XFOR

  X4 Pharmaceuticals Inc. Common Stock

  $4.05

  ▼ 4.26%
  Market cap $385.77MP/E 2.95
  $2.8$4.83
• CCCC

  C4 Therapeutics Inc. Common Stock

  $3.85

  ▼ 6.10%
  Market cap $386.99MP/E —
  $1.69$5.17
• NMRA

  Neumora Therapeutics Inc. Common Stock

  $1.38

  ▼ 6.76%
  Market cap $303.87MP/E —
  $0.83015$3.65

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) Estimate
  Benzinga · 8/12/2026

• Douglas Carr · August 3, 2026 · Sale

  275 @ $1.98
• Gregory Russotti · June 12, 2026 · Sale

  2.6K @ $2.23
• Douglas Carr · June 12, 2026 · Sale

  1.7K @ $2.23
• Chad Cowan · June 11, 2026 · Tax Withholding

  358 @ $2.24
• Brent Pfeiffenberger · June 11, 2026 · Tax Withholding

  13.8K @ $2.24
• Murphy Martin Patrick · June 11, 2026 · Grant

  74.0K
• Lee Han Myung · June 11, 2026 · Grant

  74.0K
• Alessandro Riva · June 11, 2026 · Grant

  74.0K
• Blackwell Kimberly · June 11, 2026 · Grant

  74.0K
• Quimi Daphne · June 11, 2026 · Grant

  74.0K
• Gregory Russotti · June 8, 2026 · Sale

  524 @ $2.11
• Douglas Carr · June 8, 2026 · Sale

  249 @ $2.11
• Brent Pfeiffenberger · June 5, 2026 · Tax Withholding

  463 @ $2.13
• Brent Pfeiffenberger · May 15, 2026 · Tax Withholding

  31.2K @ $2.34
• Douglas Carr · May 4, 2026 · Sale

  264 @ $2.34

Institutional Ownership

March 31, 2026

Total shares held

136.66M

Total value held

$306.92M

Institutional holders

70